Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Pharma
Pfizer CEO, Otsuka, Novartis-MSN—Fierce Pharma Asia
Pfizer CEO discusses due diligence on the 3SBio deal. Otsuka details phase 3 IgAN win. Novartis pushes for a speedy Entresto ruling.
Angus Liu
Jun 13, 2025 9:18am
EHA: Gearing up for US comeback, GSK details Blenrep's PFS win
Jun 12, 2025 9:25am
Theravance sells remaining Trelegy royalties to GSK for $225M
Jun 2, 2025 9:18am
Scynexis says GSK on hook for $10M after trial starts back up
May 28, 2025 11:54am
CHMP signs off on GSK's comeback ADC cancer drug Blenrep
May 23, 2025 11:23am
GSK revs up launch plans after Nucala's FDA approval in COPD
May 22, 2025 3:10pm
